General Information of the Compound
| Compound ID |
CP0388034
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
7-[(2R)-2-[(E,3S)-3-hydroxy-4-phenylbut-1-enyl]-5-sulfanylidenepyrrolidin-1-yl]heptanoic acid
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C21H29NO3S
|
||||||||||||||||||
| Molecular Weight |
375.534
|
||||||||||||||||||
| Canonical SMILES |
O[C@@H](Cc1ccccc1)\C=C\[C@H]1CCC(=S)N1CCCCCCC(O)=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C21H29NO3S/c23-19(16-17-8-4-3-5-9-17)13-11-18-12-14-20(26)22(18)15-7-2-1-6-10-21(24)25/h3-5,8-9,11,13,18-19,23H,1-2,6-7,10,12,14-16H2,(H,24,25)/b13-11+/t18-,19+/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
CNIZRWKAPUNIBQ-VJKINUSGSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02988, Prostaglandin E2 receptor EP1 subtype
Protein ID: PT02989, Prostaglandin E2 receptor EP2 subtype
Protein ID: PT02345, Prostaglandin E2 receptor EP3 subtype
Protein ID: PT04548, Prostaglandin E2 receptor EP4 subtype
Protein ID: PT02346, Prostaglandin E2 receptor EP4 subtype